IPL for Pigmentation Reduction
-
Intense pulsed light (IPL) is a type of light covering a narrow spectrum of wavelengths which can be used to target pigmentation in the skin.
The procedure involves application of a cooling gel to the treatment areas, followed by the IPL machine which will be moved along the skin in a methodical grid pattern to ensure even pigment reduction. Safety glasses are provided to ensure the eyes are protected from stray light rays.
-
IPL works on the basis of ‘selective thermolysis’ where certain wavelengths of light are preferentially absorbed by pigment in the skin such as the red haemoglobin in disorganised blood vessels (telangiectasia) or the melanin in freckles and sun spots. Absorption of the light by these pigments at an appropriate energy level causes their destruction.
-
The sensation will feel like a short warm zap as the light is applied to the skin - similar to laser hair removal for those who have experienced that before.
-
When targeting pigmented lesions, it is important to only target the selected melanin or haemoglobin in the particular skin lesion and to avoid accidentally targeting the naturally occurring melanin in the surrounding skin to prevent burns. This means that IPL is most safe when being performed on lighter skin types who have less naturally occurring melanin to reduce these risks (e.g. Fitzpatrick skin types 1-3).
Your therapist will determine your skin type and suitability at your initial consultation and recommend other therapies for targeting pigmentation if you are not a suitable candidate for IPL.
As a general rule of thumb, we would not recommend IPL procedures for individuals who:
Are pregnant or breastfeeding
Have been on oral isotretinoin in the last 6 months
Have had any recent sunburn or fake tan
Have any suspicious pigmented lesions in the treatment area until clearance from a medical doctor has been given
-
IPL devices use a narrow spectrum of light whereas laser devices utilise a singular wavelength of light. In IPL devices, changing the device filters allows different spectrums of light to be chosen and used to target a variety of different skin concerns. However, in lasers, a single laser device can only have a single wavelength (colour) output, and hence can only treat one concern. Moreover, lasers often emit stronger fluence (power) of light, which can increase the risk of burns or post-inflammatory hyperpigmentation if used incorrectly.
In terms of efficacy in pigmentation reduction and hair removal, the results are comparable between IPL and laser devices.
-
Treatment time depends on the size of the area being treated. A full face treatment for general improvement of skin tone should take around 30 minutes. For treatment of other body areas such as full face and neck, or neck and chest areas, or the back, the treatment time may require up to 1 hour.
During your initial consultation, your therapist will assess the size of the treatment areas and inform you on the time required for treatment. Treatment of different body areas can also be split across multiple days based on your convenience and scheduling.
-
IPL treatment does not involve any downtime as there is no injury to the skin. There may be some local redness, swelling and sensitivity of the skin in the first 24 hours, which can be alleviated with the IPL aftercare lotion which will be supplied after each treatment.
For clients seeking IPL for pigmentation reduction, please note that it is expected for the pigment to initially darken immediately after the treatment. This is called micro-crusting and is a positive and required sign that the pigment has been lifted to the surface, and will crust and fall off by itself in 1-2 weeks. Makeup can be applied as usual as long as removal of said makeup does not require aggressive rubbing that may cause the micro-crusting to fall off prematurely.
-
After an IPL procedure, it is recommended to:
Avoid active skincare ingredients (such as vitamin A or C) until the skin is no longer flushed, crusting, or sensitive
Ensure good sun protection (SPF50+ UVA/UVB) daily and avoid unprotected sun exposure - especially for clients seeking IPL for pigmentation reduction
Avoid heating-inducing activities (such as as hot showers, saunas) and environmental chemicals (such as swimming in chlorinated pools) for 48 hours after the procedure
Not pick or pull at any micro-crusting as this may incur a risk of further pigmentation, infection or scarring
Apply the supplied IPL aftercare lotion as instructed or required to support the skin’s healing process
-
It is recommended that:
Individuals with a history of herpes or cold sores may wish to take prophylactic antiviral medications before the treatment to prevent any onset
Individuals should not undergo any waxing or other procedures that can cause trauma to the skin prior to the treatment
Individuals should not undergo any recent sunburn, tanning or self-tanning as this may influence the safety and efficacy of the IPL procedure
Individuals using topical photosensitising medications on the treatment areas such as vitamin A derivatives or benzoyl peroxide should discontinue use 48 hours prior to an IPL procedure, and only restart 24 hours after the treatment
Individuals using hydroquinone should discontinued use 7 days prior to an IPL treatment, and only restart 24hr after the treatment. For clients undergoing a course of IPL treatments, hydroquinone should not be restarted until 24 hours after the last treatment in the course
-
For removal of pigmented lesions, IPL is generally recommended to be done in 1-2 sessions spaced 4-6 weeks apart with the second session only indicated if further treatment is required.
-
Gade, Anita, et al. "Intense pulsed light (IPL) therapy." StatPearls [Internet]. StatPearls Publishing, 2024.
DiBernardo, Barry E., and Jason N. Pozner. "Intense pulsed light therapy for skin rejuvenation." Clinics in plastic surgery 43.3 (2016): 535-540.
Ross, E. Victor, et al. "Intense pulsed light and laser treatment of facial telangiectasias and dyspigmentation: some theoretical and practical comparisons." Dermatologic surgery 31 (2005): 1188-1198.